KR20190100205A - 당뇨성 말초 신경병증 치료용 물품 - Google Patents
당뇨성 말초 신경병증 치료용 물품 Download PDFInfo
- Publication number
- KR20190100205A KR20190100205A KR1020197018171A KR20197018171A KR20190100205A KR 20190100205 A KR20190100205 A KR 20190100205A KR 1020197018171 A KR1020197018171 A KR 1020197018171A KR 20197018171 A KR20197018171 A KR 20197018171A KR 20190100205 A KR20190100205 A KR 20190100205A
- Authority
- KR
- South Korea
- Prior art keywords
- article
- peripheral neuropathy
- tissue
- target
- electrical stimulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000032131 Diabetic Neuropathies Diseases 0.000 title claims description 30
- 230000000638 stimulation Effects 0.000 claims abstract description 98
- 210000001519 tissue Anatomy 0.000 claims abstract description 63
- 238000000034 method Methods 0.000 claims abstract description 54
- 210000000944 nerve tissue Anatomy 0.000 claims abstract description 52
- 208000033808 peripheral neuropathy Diseases 0.000 claims abstract description 47
- 230000002792 vascular Effects 0.000 claims abstract description 34
- 230000001537 neural effect Effects 0.000 claims abstract description 21
- 230000024883 vasodilation Effects 0.000 claims abstract description 16
- 208000002193 Pain Diseases 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 22
- 210000004204 blood vessel Anatomy 0.000 claims description 11
- 230000005684 electric field Effects 0.000 claims description 11
- 210000000578 peripheral nerve Anatomy 0.000 claims description 11
- 206010040030 Sensory loss Diseases 0.000 claims description 9
- 210000005036 nerve Anatomy 0.000 claims description 8
- 210000005166 vasculature Anatomy 0.000 claims description 8
- 230000010412 perfusion Effects 0.000 claims description 5
- 239000012778 molding material Substances 0.000 claims description 4
- 238000011084 recovery Methods 0.000 claims description 3
- 210000002683 foot Anatomy 0.000 description 23
- 210000003371 toe Anatomy 0.000 description 20
- 239000012530 fluid Substances 0.000 description 13
- 230000017531 blood circulation Effects 0.000 description 11
- 206010012601 diabetes mellitus Diseases 0.000 description 11
- 239000004744 fabric Substances 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 210000001367 artery Anatomy 0.000 description 6
- 230000008081 blood perfusion Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 208000035824 paresthesia Diseases 0.000 description 5
- 230000035807 sensation Effects 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- 239000004020 conductor Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 229920002120 photoresistant polymer Polymers 0.000 description 4
- 208000000094 Chronic Pain Diseases 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 238000005229 chemical vapour deposition Methods 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 description 2
- 102000004414 Calcitonin Gene-Related Peptide Human genes 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010049567 Miller Fisher syndrome Diseases 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 241000220010 Rhode Species 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 208000003295 carpal tunnel syndrome Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- -1 etc.) Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000000976 ink Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000007383 nerve stimulation Effects 0.000 description 2
- 201000001119 neuropathy Diseases 0.000 description 2
- 230000007823 neuropathy Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000004544 sputter deposition Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 239000003039 volatile agent Substances 0.000 description 2
- 208000003808 Amyloid Neuropathies Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010068597 Bulbospinal muscular atrophy congenital Diseases 0.000 description 1
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical class C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000017899 Foot injury Diseases 0.000 description 1
- 208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
- 208000011092 Hand injury Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000027747 Kennedy disease Diseases 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 206010029174 Nerve compression Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 208000001163 Tangier disease Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 208000007642 Vitamin B Deficiency Diseases 0.000 description 1
- 206010047627 Vitamin deficiencies Diseases 0.000 description 1
- 208000006269 X-Linked Bulbo-Spinal Atrophy Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000012984 antibiotic solution Substances 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- 239000005441 aurora Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000005465 channeling Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000013481 data capture Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008482 dysregulation Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002357 endometrial effect Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 229910003472 fullerene Inorganic materials 0.000 description 1
- 229910021397 glassy carbon Inorganic materials 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000037427 ion transport Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000008720 membrane thickening Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 210000001872 metatarsal bone Anatomy 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 229910021392 nanocarbon Inorganic materials 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 230000006764 neuronal dysfunction Effects 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000012811 non-conductive material Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229940005483 opioid analgesics Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 208000027232 peripheral nervous system disease Diseases 0.000 description 1
- 238000005240 physical vapour deposition Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920005596 polymer binder Polymers 0.000 description 1
- 239000002491 polymer binding agent Substances 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 238000005546 reactive sputtering Methods 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 210000002265 sensory receptor cell Anatomy 0.000 description 1
- 102000027509 sensory receptors Human genes 0.000 description 1
- 108091008691 sensory receptors Proteins 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 206010048627 thoracic outlet syndrome Diseases 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
- 229940100640 transdermal system Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000036722 ulnar neuropathy Diseases 0.000 description 1
- 230000004855 vascular circulation Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36021—External stimulators, e.g. with patch electrodes for treatment of pain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0484—Garment electrodes worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36017—External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36034—Control systems specified by the stimulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/3615—Intensity
- A61N1/36153—Voltage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/3615—Intensity
- A61N1/36157—Current
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36167—Timing, e.g. stimulation onset
- A61N1/36171—Frequency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36167—Timing, e.g. stimulation onset
- A61N1/36175—Pulse width or duty cycle
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662439283P | 2016-12-27 | 2016-12-27 | |
| US62/439,283 | 2016-12-27 | ||
| PCT/US2017/065243 WO2018125538A1 (en) | 2016-12-27 | 2017-12-08 | Article for treating diabetic peripheral neuropathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20190100205A true KR20190100205A (ko) | 2019-08-28 |
Family
ID=60888650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020197018171A Withdrawn KR20190100205A (ko) | 2016-12-27 | 2017-12-08 | 당뇨성 말초 신경병증 치료용 물품 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11471677B2 (https=) |
| EP (1) | EP3562541B1 (https=) |
| JP (1) | JP2020503111A (https=) |
| KR (1) | KR20190100205A (https=) |
| AU (1) | AU2017387791B2 (https=) |
| MX (1) | MX2019007714A (https=) |
| WO (1) | WO2018125538A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023191236A1 (ko) * | 2022-03-30 | 2023-10-05 | (주)웨이브트리 | 손 또는 발 부위의 말초신경 자극장치 |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9833614B1 (en) | 2012-06-22 | 2017-12-05 | Nevro Corp. | Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods |
| US12453853B2 (en) | 2013-01-21 | 2025-10-28 | Cala Health, Inc. | Multi-modal stimulation for treating tremor |
| EP3498332B1 (en) | 2013-01-21 | 2021-07-14 | Cala Health, Inc. | Devices for controlling tremor |
| AU2015271774B2 (en) | 2014-06-02 | 2020-04-16 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation to treat tremor |
| CN119565022A (zh) | 2015-06-10 | 2025-03-07 | 卡拉健康公司 | 用于外周神经刺激以利用可拆卸治疗和监测单元治疗震颤的系统和方法 |
| US20180001107A1 (en) | 2016-07-01 | 2018-01-04 | Btl Holdings Limited | Aesthetic method of biological structure treatment by magnetic field |
| US10695575B1 (en) | 2016-05-10 | 2020-06-30 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
| WO2017023864A1 (en) | 2015-07-31 | 2017-02-09 | Cala Health, Inc. | Systems, devices, and method for the treatment of osteoarthritis |
| EP3352843B1 (en) | 2015-09-23 | 2021-06-23 | Cala Health, Inc. | Device for peripheral nerve stimulation in the finger to treat hand tremors |
| WO2017132067A2 (en) | 2016-01-21 | 2017-08-03 | Cala Health, Inc. | Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder |
| US11464993B2 (en) | 2016-05-03 | 2022-10-11 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
| CN109803717B (zh) | 2016-08-25 | 2024-01-09 | 卡拉健康公司 | 通过周围神经刺激治疗心脏机能障碍的系统和方法 |
| US20180272132A1 (en) | 2017-01-19 | 2018-09-27 | Nevro Corp. | High frequency stimulation for treating sensory and/or motor deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods |
| EP3606604A4 (en) | 2017-04-03 | 2020-12-16 | Cala Health, Inc. | PERIPHERAL NEUROMODULATION SYSTEMS, METHODS AND DEVICES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH BLADDER HYPERACTIVITY |
| US11857778B2 (en) | 2018-01-17 | 2024-01-02 | Cala Health, Inc. | Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation |
| FR3092496B1 (fr) | 2018-12-07 | 2025-05-30 | Avent Inc | Dispositif et procede pour moduler de maniere selective et reversible une structure du systeme nerveux afin d’inhiber la douleur |
| US12558146B2 (en) | 2019-04-11 | 2026-02-24 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US12251560B1 (en) | 2019-08-13 | 2025-03-18 | Cala Health, Inc. | Connection quality determination for wearable neurostimulation systems |
| US11890468B1 (en) | 2019-10-03 | 2024-02-06 | Cala Health, Inc. | Neurostimulation systems with event pattern detection and classification |
| US20210121682A1 (en) * | 2019-10-27 | 2021-04-29 | Texas Woman's University | Sock that wirelessly delivers electrical signals directly to the foot and ankle muscles for the treatment of pain |
| BR112022022112A2 (pt) | 2020-05-04 | 2022-12-13 | Btl Healthcare Technologies As | Dispositivo para tratamento não assistido do paciente |
| US11878167B2 (en) | 2020-05-04 | 2024-01-23 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US12350490B2 (en) * | 2022-05-04 | 2025-07-08 | Neurological Fitness Equipment and Education LLC | Electrotherapy glove for delivery of amplitude modulated pulsed direct current during manual therapy treatment |
| GB2619011A (en) * | 2022-05-19 | 2023-11-29 | Guys And St Thomas Nhs Found Trust | Apparatus and method for causing vasoconstriction by electrical stimulation |
| AU2023299284A1 (en) | 2022-07-01 | 2025-01-16 | Nevro Corp. | Neurostimulation for treating sensory deficits, and associated systems and methods |
| US12491363B2 (en) | 2023-03-24 | 2025-12-09 | Taiwan Resonant Waves Research Corp. | Electrical stimulation system and a method thereof |
| AU2023201838B2 (en) * | 2023-03-24 | 2024-11-21 | Taiwan Resonant Waves Research Corp. | Electrical stimulation system and a method thereof |
| EP4727638A1 (en) * | 2023-05-09 | 2026-04-22 | Nevro Corp. | Long pulse width spinal cord stimulation for treating diabetic neuropathy, and associated systems and methods |
| US20250018173A1 (en) * | 2023-07-10 | 2025-01-16 | Steve O'neal | Sensory Control System |
| WO2025042775A1 (en) * | 2023-08-18 | 2025-02-27 | Stimmed Llc | Method and apparatus for noninvasive inhibition of deep vein thrombosis |
| US20260097225A1 (en) | 2024-10-08 | 2026-04-09 | Btl Medical Solutions A.S. | Devices and methods for application of a magnetic field to the nervous system |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4521365A (en) | 1983-12-20 | 1985-06-04 | Bio Research Inc. | Glove molding apparatus and method |
| US5693401A (en) | 1996-05-01 | 1997-12-02 | Kimberly-Clark Worldwide, Inc. | Surgical glove retainer |
| US7013179B2 (en) * | 2000-01-07 | 2006-03-14 | Biowave Corporation | Percutaneous electrode array |
| CN100402100C (zh) | 2001-06-01 | 2008-07-16 | 艾佛罗公司 | 大量负荷剂量装置及方法 |
| US20040039417A1 (en) | 2002-04-16 | 2004-02-26 | Medtronic, Inc. | Electrical stimulation and thrombolytic therapy |
| US6745078B1 (en) * | 2002-04-24 | 2004-06-01 | Kelly W. Buchner | Procedure and machine for electro-inducing/stimulating deep-layered muscle contractions using a biphasic faradic pulse sequence |
| KR20050122205A (ko) * | 2003-03-06 | 2005-12-28 | 애퍼런트 코퍼레이션 | 인체밸런스와 보행 향상 및 발부상 방지를 위한 장치 및 그방법 |
| CA2876835C (en) * | 2003-06-24 | 2020-06-30 | Medrelief Inc. | Apparatus and method for bioelectric stimulation, healing acceleration, pain relief, or pathogen devitalization |
| JP4057558B2 (ja) * | 2004-06-09 | 2008-03-05 | 伊藤超短波株式会社 | 筋肉トレーニング装置 |
| EP1804905B1 (en) * | 2004-10-05 | 2016-02-17 | Medtronic Ardian Luxembourg S.à.r.l. | Apparatus for renal neuromodulation |
| US7542804B2 (en) * | 2004-12-03 | 2009-06-02 | Alfred E. Mann Foundation For Scientific Research | Neuromuscular stimulation to avoid pulmonary embolisms |
| US9339641B2 (en) * | 2006-01-17 | 2016-05-17 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
| WO2007088547A2 (en) * | 2006-02-02 | 2007-08-09 | Tylerton International Inc. | Metabolic sink |
| EP1981584B1 (en) * | 2006-02-03 | 2015-05-13 | Interventional Autonomics Corporation | Intravascular device for neuromodulation |
| WO2008005478A2 (en) * | 2006-07-05 | 2008-01-10 | Brainvital Corporation | Treatment of neurological disorders via electrical stimulation, and methods related thereto |
| US20080195176A1 (en) * | 2007-02-12 | 2008-08-14 | The Research Foundation Of State University Of New York | Raynaud's Conditions |
| CA2768835A1 (en) * | 2009-07-23 | 2011-01-27 | Emkinetics, Inc. | Method and apparatus for magnetic induction therapy |
| KR100994208B1 (ko) * | 2009-07-28 | 2010-11-12 | 이지훈 | 미세전류 자극용 양말 |
| KR20130133262A (ko) * | 2010-12-30 | 2013-12-06 | 더 호스피탈 포 식 칠드런 | 비침습적 전기 신경 자극 관련 방법 및 장치 |
| US9271864B2 (en) * | 2011-10-04 | 2016-03-01 | Feinstein Patents Llc | Orthosis for range of motion, muscular and neurologic rehabilitation of the lower extremities |
| US10092750B2 (en) | 2011-11-11 | 2018-10-09 | Neuroenabling Technologies, Inc. | Transcutaneous neuromodulation system and methods of using same |
| US8958886B2 (en) * | 2012-12-31 | 2015-02-17 | Kimberly-Clark Worldwide, Inc. | Method and apparatus to increase tactile senstivity and proprioception in humans |
| JPWO2014136852A1 (ja) * | 2013-03-06 | 2017-02-16 | 学校法人 久留米大学 | 電気刺激装置 |
| WO2014164438A1 (en) * | 2013-03-11 | 2014-10-09 | Ohio State Innovation Foundation | Devices and systems for treating obstetric and gynecological disorders |
| EP2968910A4 (en) | 2013-03-15 | 2016-11-02 | Emkinetics Inc | METHOD AND APPARATUS FOR TRANSDERMAL STIMULATION ON PALMARY AND PLANTAIRE SURFACES |
| GB2531619A (en) * | 2014-09-12 | 2016-04-27 | Innovarius Ltd | Apparatus and method for providing hyperthermia therapy |
| CN107106841B (zh) * | 2014-10-31 | 2021-06-25 | 阿文特公司 | 经由胫后神经刺激来监测和治疗病症的方法和系统 |
| US10092738B2 (en) * | 2014-12-29 | 2018-10-09 | Ethicon Llc | Methods and devices for inhibiting nerves when activating brown adipose tissue |
| US10080884B2 (en) * | 2014-12-29 | 2018-09-25 | Ethicon Llc | Methods and devices for activating brown adipose tissue using electrical energy |
| CN108778403B (zh) * | 2015-12-22 | 2022-09-13 | 明尼苏达大学董事会 | 提供交感神经调制治疗的系统 |
-
2017
- 2017-12-08 MX MX2019007714A patent/MX2019007714A/es unknown
- 2017-12-08 US US16/469,182 patent/US11471677B2/en active Active
- 2017-12-08 EP EP17822881.3A patent/EP3562541B1/en active Active
- 2017-12-08 KR KR1020197018171A patent/KR20190100205A/ko not_active Withdrawn
- 2017-12-08 AU AU2017387791A patent/AU2017387791B2/en not_active Ceased
- 2017-12-08 WO PCT/US2017/065243 patent/WO2018125538A1/en not_active Ceased
- 2017-12-08 JP JP2019534277A patent/JP2020503111A/ja active Pending
-
2022
- 2022-09-09 US US17/930,787 patent/US20230001202A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023191236A1 (ko) * | 2022-03-30 | 2023-10-05 | (주)웨이브트리 | 손 또는 발 부위의 말초신경 자극장치 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20230001202A1 (en) | 2023-01-05 |
| AU2017387791A1 (en) | 2019-06-13 |
| EP3562541A1 (en) | 2019-11-06 |
| US20200023183A1 (en) | 2020-01-23 |
| JP2020503111A (ja) | 2020-01-30 |
| MX2019007714A (es) | 2019-09-09 |
| US11471677B2 (en) | 2022-10-18 |
| EP3562541B1 (en) | 2021-07-14 |
| WO2018125538A1 (en) | 2018-07-05 |
| AU2017387791B2 (en) | 2022-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230001202A1 (en) | Article and method for treating diabetic peripheral neuropathy | |
| Lee et al. | Mechano-neuromodulation of autonomic pelvic nerve for underactive bladder: A triboelectric neurostimulator integrated with flexible neural clip interface | |
| JP4879754B2 (ja) | 移植された非活性導電体を介して、身体組織に電流を搬送する方法 | |
| US8560075B2 (en) | Apparatus and method for the treatment of headache | |
| AU2013368951B2 (en) | Method and apparatus to increase tactile sensitivity and proprioception in humans | |
| US20240325728A1 (en) | Electrodes for neuromodulation | |
| US20090326602A1 (en) | Treatment of indications using electrical stimulation | |
| US20150257970A1 (en) | Device and method for reducing pain | |
| CN108136177A (zh) | 用于对脊髓进行经皮电刺激的电极阵列及其用途 | |
| AU2007207297A1 (en) | Method of routing electrical current to bodily tissues via implanted passive conductors | |
| WO1994015527A1 (en) | Medical electrode system | |
| Micera et al. | Wearable neural prostheses | |
| US20230248962A1 (en) | System, method, and apparatus for applying bilateral transcutaneous electrical stimulation | |
| Greig et al. | Electrical stimulation for wound healing: opportunities for E-textiles | |
| US20130253412A1 (en) | Roller-ball applicator for transdermal iontophoretic delivery | |
| CN108136176A (zh) | 制造用于脊髓的经皮电刺激的电极阵列的方法 | |
| CN110404164A (zh) | 脊髓闭环性电刺激系统 | |
| Naito et al. | Inhibitory projections from pronator teres to biceps brachii motoneurones in human | |
| KR101242553B1 (ko) | 전기침 플랫폼 | |
| EP4048372A1 (en) | Method and apparatus for controlling multi-site neurostimulation | |
| Torregrosa et al. | Bioelectric medicine and devices for the treatment of spinal cord injury | |
| Cooper et al. | Review articles: Minimizing fatigue for functional electrical stimulation of muscle | |
| RAGNARSSON | The physiologic aspects and clinical application of functional electrical stimulation in rehabilitation | |
| CN121606810A (zh) | 多模式上肢矫正锻炼器 | |
| DiLorenzo et al. | History and overview of neural engineering |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20190624 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination |